Category Archives: News

KBP BioSciences submitted IND of KBP-7072 to the cFDA

Jinan, China and Princeton, New Jersey, USA (May 2015) KBP BioSciences, a clinical stage biotech company with operations in China, US, and Singapore, today announced that the China FDA (cFDA) accepted an Initial New Drug Application (IND) for its experimental drug KBP-7072 for the potential treatment of serious bacterial infections. KBP-7072 is a next generation

Read More

The US FDA approved KBP-5074 to enter clinical trial

Jinan, China and Princeton, New Jersey, USA (Feb 10, 2014) KBP BioSciences, a clinical stage biotech company with operations in China, US, and Singapore, today announced that the US FDA approved KBP-5074 to enter clinical trials for the potential treatment of chronic kidney disease (CKD). This is KBP’s first clinical project in the US. Roughly

Read More